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Introduction
A fundamental freedom to receive cross border medical treatment is 
granted to citizens of the European Union under the internal market 
provisions of European Community Law.1 The European Court of Ju­
stice has interpreted the extent of, and the limits to, this freedom in 
a series of rulings,2 the most recent and controversial being the ruling 
delivered in the case of Yvonne Watts v Bedford Primary Care Trust,3
1 Article 49 of the European Community Treaty, Joined Cases 286/82 and 26/83 Luisi and 
Carbone.
2 Case C-158/96 Kohll; Case C-120/95 Decker; Case C-368/98 Vanbraekel; Case C-157/99 
Geraets Smits and Peerbooms; Case C-385/99 Muller-Faure and van Riet; Case C-56/01 Inizan.
3 Case C-372/04, The Queen, on the application o f Yvonne Watts v Bedford Primary Care 
Trust and Secretary of State for Health. Judgment of the Court (Grand Chamber), 16th May 
2006. Opinion of Advocate General Geelhoed delivered on 15 December 2005. Reference for 
a preliminary ruling under Article 234 of the European Community Treaty from the Court of
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in May 2006. Competence in the field of public health is retained by 
individual Member States who each have the responsibility for orga­
nising and delivering health services and medical care.4 The European 
Court of Justice acknowledges the need to balance the objective of the 
free movement of patients against overriding national objectives rela­
ting to management of the available hospital capacity, control of health 
expenditure and financial balance of social security systems.5 Nevert­
heless, the Court ruled, in the Watts case that this does not exclude 
the possibility that Member States may be required under European 
Community law to make adjustments to their social security systems.6 
An obligation exists under Community law to authorise a patient re­
gistered with a national health service to obtain, at that institution’s 
expense, hospital treatment in another Member State where the wai­
ting time exceeds an acceptable period having regard to an objective 
medical assessment of the condition and clinical requirements of the 
patient concerned.7
It is the intention of this paper to assess the extent of, and the bar­
riers that exist to, the freedom to choose to have urgent hospital treat­
ment in another European Union Member State. This paper will also 
treat the Consultation on the need for Community action on health 
services,8 undertaken in order to establish legal certainty for patients 
and for Member States. In particular, the response of the United King­
dom Government will be examined.9 Some tentative conclusions will 
be drawn.
Appeal (England and Wales) (Civil Division) (United Kingdom), made by order of 12 July 2004.
4 Article 152(5) of the European Community Treaty.
5 Case C-372/04, para. 145 of the judgment.
6 Ibidem, para. 147.
7 Ibidem, para. 148.
8 Commission Communication, “Consultation regarding Community action on health ser­
vices”, SEC (2006) 1195/4, 26 September 2006.
9 UK Consultation Response to Commission Communication on Health Services, available 
on the Internet: http://ec.europa.eu/health/ph_overview/co-operation/mobility/results_open_ 
consultation_en.htm#1.
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Reimbursement of cross-border hospital treatment from a National 
Health Service
The case of Yvonne Watts concerned a reference for a preliminary 
ruling under Article 234 of the European Community Treaty from 
the Court of Appeal (England and Wales) (Civil Division), made in 
the course of proceedings arising from the refusal of Bedford Primary 
Care Trust to reimburse the cost of a hip replacement operation re­
ceived in France and paid for directly by Mrs Watts, who resides in 
the United Kingdom.10 Mrs Watts based her appeal on the dismissal 
of her application for reimbursement of the cost of treatment from the 
NHS and on the fact that the waiting time applicable in national law 
was a relevant factor in applying Article 49 EC. In the United Kingdom 
National Health Service (NHS), hospital care is provided free of charge 
to all persons ordinarily resident in the United Kingdom. Treatment is 
funded directly by the State, essentially from general taxation revenue 
which is apportioned between Primary Care Trusts (PCTs). Access to 
hospital treatment is dependent on referral by a general practitioner. 
The NHS makes use of the available resources by setting priorities, 
which results in some quite lengthy waiting lists for less urgent treat­
ment. NHS bodies determine, within the limits of the budgetary provi­
sion made available to them, the weighting of clinical priorities within 
national guidelines.11
The United Kingdom Government maintained that NHS patients 
were not entitled to rely on Community law prescribing the freedom 
of movement to receive medical treatment in another European Union 
Member State. The European Court of Justice noted in that regard that, 
according to settled case-law, medical services provided for consider­
ation fall within the scope of the provisions on the freedom to provide
10 Case C-372/04, paras. 1 and 2. Mrs Yvonne Watt’s case had been diagnosed by a Consul­
tant in the United Kingdom as being ‘routine’ in the first instance. On review she was categorised 
as requiring surgery ‘soon, a category between the most urgent cases and the routine cases. Ibi­
dem, paras. 25 and 29.
11 Ibidem, paras. 8, 9, 12, 13 and 15.
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services,12 there being no need to distinguish between care provided 
in a hospital environment and care provided outside such an environ­
m ent.13 Also, that it had been held that the freedom to provide services 
includes the freedom for the recipients of services, including persons 
in need of medical treatment, to go to another Member State in or­
der to receive those services there.14 The Court ruled that the fact that 
reimbursement of the hospital treatment in question is subsequently 
sought from a national health service ... does not mean that the rules 
on the freedom to provide services guaranteed by the Treaty do not 
apply.15 It further ruled that it has already been held that a supply of 
medical services does not cease to be a supply of services within the 
meaning of Article 49 EC on the ground that the patient after paying 
the foreign supplier for the treatment received, subsequently seeks the 
reimbursement of that treatment from a national health service.16
The Court therefore found that Article 49 EC applies where a pa­
tient receives medical services in a hospital environment for consider­
ation in a Member State other than her State of residence, regardless 
of the way in which the national system with which that person is reg­
istered and from which reimbursement of the cost of those services is 
subsequently sought operates.17
What is the extent of, and what are the barriers that exist to, the free­
dom to choose to have urgent hospital treatment in another European 
Union Member State at the expense of the Member State of residence?
12 See: inter alia, case C-159/90 Society for the Protection of Unborn Children Ireland [1991] 
ECR I-4685, para. 18, and Case C-158/96 Kohl, para. 29.
13 Case C-368/98 Vanbraekel, para. 41; Case C-157/99 Smits and Peerbooms, para. 53; Case C- 
385/99 Muller-Faure and van Riet, para. 38; Case C-56/01 Inizan, para. 16. Case 372/04, para. 86.
14 See: Joined Cases 286/82 and 26/83 Luisi and Carbone [1984] ECR 377, para. 16, Case 
C-372/04, para. 87.
15 See to that effect: Smits and Peerbooms, para. 55, and Muller-Faure and van Riet, para. 39.
16 See: Muller-Faure and van Riet, para. 103; Case C-372/04, para. 88.
17 There being no need in the present case to determine whether the provision of hospital 
treatment in the context of a national health service such as the NHS is itself a service within the 
meaning of Article 49. Ibidem, para. 90.
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a) No unjustified restrictions: prior authorisation subject to the 
principle of proportionality
The Grand Chamber of the European Court of Justice continued 
by stating that whilst it is not in dispute that Community law does not 
detract from the power of the Member States to organise their social 
security systems, and that, in the absence of harmonisation at Com­
munity level, it is for the legislation of each Member State to determine 
the conditions in which social security benefits are granted, when ex­
ercising that power Member States must comply with Community law, 
in particular the provisions on the freedom to provide services.18 Those 
provisions prohibit the Member States from introducing or maintain­
ing unjustified restrictions on the exercise of that freedom in the health 
care sector.19
Prior authorisation is a prerequisite for the NHS to assume the 
costs of hospital treatm ent available in another Member State. In 
the opinion of the Court, the system of prior authorisation deters, 
or even prevents patients from applying to providers of hospital ser­
vices established in anther Member State and constitutes an obsta­
cle/restriction to the freedom to receive and to provide services.20 
Nevertheless, such restriction is, according to the Court, capable of 
objective justification by, inter alia: overriding reasons in the general 
interest, such as the risk of seriously underm ining the financial bal­
ance of a social security system;21 and the objective of maintaining 
a balanced medical and hospital service open to all.22 The Court was 
of the view that planning hospital medical care must be possible in
18 See: inter alia, Smits and Peerbooms, para. 44 to 46; Müller-Faure and van Riet, para. 100; 
Inizan, para. 17.
19 Case 372/04, para. 92.
20 See to that effect: Smits and Peerbooms, para. 69, Müller-Faure and van Riet, para. 44; 
ibidem, para. 98.
21 Kohll, para. 41; Smits and Peerbooms, para. 72; Müller-Faure and van Riet, para. 73; ibidem, 
paras. 101 and 103.
22 Kohll, para. 50; Smits and Peerbooms, para. 73; Müller-Faure and van Riet, para. 67; ibidem, 
para. 104.
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order to ensure sufficient and perm anent access to a balanced range 
of high-quality hospital treatment in the State concerned. Planning, 
furthermore, assists in meeting a desire to control costs and to pre­
vent, as far as possible, any wastage of financial, technical and hu­
man resources. The hospital care sector generates considerable costs 
and must satisfy increasing needs, while the financial resources that 
may be made available for healthcare are not unlimited. From these 
two points of view, the Court concluded that the requirement that 
the assumption of costs by the national system of hospital treatment 
provided in another Member State be subject to prior authorisation 
appeared to be a measure which was both necessary and reasonable 
and thus not precluded by Community law and in particular Article 
49 EC.23
b) Conditions attached to grant of prior authorisation must be pro­
portionate; and based on objective, non-discriminatory criteria known 
in advance in order to circumscribe the exercise of national authori­
ties’ discretion: A procedure
The conditions attached to the grant of such authorisation must be 
justified in the light of the overriding considerations of the Member 
State and must satisfy the requirement of proportionality, ruled the 
Court.24 Thus, in order for the system of prior authorisation to be justi­
fied, “it must be based on objective, non-discriminatory criteria which 
are known in advance, in such a way as to circumscribe the exercise of 
the national authorities’ discretion, so that it is not used arbitrarily.
It must be based on a procedural system which is easily accessible 
and capable of ensuring that a request for authorisation will be dealt 
with objectively and impartially within a reasonable time. Moreover, 
refusals to grant authorisation must also be capable of being challen­
ged in judicial or quasi-judicial proceedings”25
23 Ibidem, paras. 109, 110 and 113.
24 See to that effect: Smits and Peerbooms, para. 82, Müller-Faure and van Riet, para. 83; 
ibidem, para. 114.
25 Smits and Peerbooms, para. 90, Müller-Faure and van Riet, para. 84 and 85; ibidem, para. 116.
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The Court noted that the Regulations on the NHS do not set out the 
criteria for the grant or refusal of the prior authorisation necessary for 
reimbursement of the cost of hospital treatment provided in another 
Member State, and therefore do not circumscribe the exercise of the 
national competent authorities’ discretionary power in that context. 
Furthermore, the lack of a legal framework in that regard also makes 
it difficult to exercise judicial review of decisions refusing to grant aut­
horisation.26
It is evident that the procedure in the United Kingdom is deficient 
in this regard. Accordingly, the United Kingdom needs to introduce 
positive changes concerning the transparency and availability of crite­
ria which are known in advance on which the decision to grant prior 
authorisation must be based and which make it possible to undertake 
judicial review of the decision taken.
c) Undue delay? The need to carry out in the individual case in 
question an objective medical assessment of the patient’s medical con­
dition, the history and probable cause of his illness, the degree of pain 
he is in and/or the nature of his disability at the time when the request 
for authorisation was made or renewed.
The Court clearly stated that “a refusal to grant prior authorisation 
could not be based merely on the existence of waiting lists intended to 
enable the supply of hospital care to be planned and managed on the 
basis of predetermined general clinical priorities, without carrying out 
in the individual case in question an objective medical assessment of 
the patient’s medical condition, the history and probable cause of his 
illness, the degree of pain he is in and/or the nature of his disability at 
the time when the request for authorisation was made or renewed.27 
It followed, therefore, that where the delay arising from such waiting 
lists appears to exceed in the individual case concerned an acceptab­
le period having regard to an objective medical assessment of all the 
circumstances of the situation and the clinical needs of the person
26 Ibidem, para. 118.
27 Ibidem, para. 119.
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concerned, the competent institution may not refuse the authorisation 
sought on the grounds of the existence of those lists, an alleged distor­
tion of the normal priorities linked to the relative urgency of the cases 
to be treated, the fact that the hospital treatment provided under the 
national system in question is free of charge, the duty to make available 
specific funds to reimburse the cost of treatment provided in another 
Member State and/or a comparison between the cost of that treatment 
and that of equivalent treatment in the competent Member State.”28
d) Mechanisms for reimbursement
It is significant in its impact on the United Kingdom that the Court 
further ruled that the need for Member States to reconcile the prin­
ciples and broad scheme of their health care system with the require­
ments arising from the Community freedoms, entails a “duty on the 
part of the competent authorities of a national health service, such as 
the NHS, to provide mechanisms for the reimbursement of the cost of 
hospital; treatment in another Member State to patients to whom that 
service is not able to provide the treatment required within a medically 
acceptable period.”29
With regard to costs, the Court went on to state that a patient regi­
stered with the NHS who was authorised to receive hospital treatment 
in another Member State or who received a refusal to authorise subse­
quently held to be unfounded, was entitled to have the cost of that tre­
atment reimbursed in full pursuant to the provisions of the legislation 
of the host Member State.30 But not where the cost of that treatment was 
greater than the cost of equivalent treatment in the competent Mem­
ber State, since that would afford the patient cover in excess of that to 
which he was entitled under the national health service with which he 
was registered.31 In that case the competent authority would only be 
required to cover up to the cost of the same treatment in the Member
28 Ibidem, para. 120.
29 Ibidem, para. 122.
30 Ibidem, para. 130.
31 Ibidem, para. 132.
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State of Residence. Article 49 EC, according to the Court, furthermore 
must be interpreted as meaning that an authorised patient is entitled 
to seek from the competent institution reimbursement of the ancillary 
costs (transport and accommodation) associated with that cross-bor­
der movement for medical purposes provided that the legislation of 
the competent Member State imposes a corresponding obligation on 
the national system to reimburse in respect of treatment provided in 
a local hospital covered by that system.32
Commission Consultation: Community Action on 
Health Services
Following the consecutive rulings in which the European Court of Ju­
stice interpreted European Community law in favour of the internal 
market in health care, there was a call for clarity of the law by insti­
tutional actors as opposed to rulings emanating from the Court.33 In 
response, the European Commission, in a Communication Regarding 
Community Action on Health Services,34 has engaged in a Consul­
tation process with all interested parties with the stated objective of 
achieving legal certainty concerning cross-border health care for both
32 Ibidem, para. 143. It was for the referring court, in this case the UK Court of Appeal, to 
determine whether the United Kingdom rules provide for the assumption of ancialliary costs as­
sociated with cross-border movement authorised for medical purposes. Para. 141.
33 See further Council Conclusions on Common values and principles in EU Health Systems, 
2733rd Employment, Social Policy, Health and Consumer Affairs Council meeting, Luxembourg, 
1-2 June 2006, http://www.consilium.europa.eu/Newsroom. “The Council recognises that recent 
judgments in the European Court of Justice have highlighted the need to clarify the interaction 
between the EC Treaty provisions, particularly on the free movement of services and the health 
services provided by national health systems”. Point 3 of the Council conclusions.
34 SEC (2006) 1195/4, 26 September 2006. Therein, the Commission explains that the Com­
mission proposal for a Directive on Services in the Internal Market (COM (2004) 2, 13 January 
2004) included proposals codifying the rulings of the European Court of Justice in applying free 
movement principles to health services but that this approach was not considered to be appropri­
ate by the European Parliament and the Council, which institutions invited the Commission to 
develop a specific proposal in this area.
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patients and Member States. The aim is for a clear framework of Com­
munity law in order to ensure a more general and effective application 
of the freedom to receive health services in other Member States. The 
Commission identifies the following issues which need to be addres­
sed, namely:
• there are shared values and principles for health services on which 
citizens can rely throughout the EU;
• What practical issues need to be clarified for citizens who wish to 
seek health care in another Member State;
• W hat flexibility Member States have to regulate and plan their own 
health systems without creating unjustified barriers to free move­
ment;
• How to reconcile patient choice with financial sustainability of health 
systems;
• How to ensure a financial compensation mechanism for cross-bor­
der healthcare provided by ‘receiving’ health systems;
• How patients can identify, compare or choose between providers in 
other countries.
Therein, the Commission poses a number of questions: nine in total.
• Question 1: What is the current impact of cross-border health care 
on accessibility, quality and financial sustainability of health care sy­
stems and how might this evolve?
According to the Commission, the current volume of patient m o­
bility is low, estimated at around 1% of overall public expenditure on 
health care, but a lack of data in this respect is highlighted. The Com­
mission underlines the fact that the lack of information about health 
care possibilities in other Member States and the lack of a transparent 
framework act as deterrents to seeking care abroad.
• Question 2: W hat specific legal clarification (Community action) and 
what practical information is required by whom (authorities, provi­
ders, patients)?
Clarification is suggested of the condition that authorisation for care 
abroad must be granted if such care cannot be provided in the member
Pa t i e n t  M o b i l i t y  i n  t h e  E u r o p e a n  U n i o n . 89
state of residence without ‘undue delay. Although the Commission is of 
the view that this should focus more on processes for consideration rather 
than setting any specific period. Mechanisms are advocated through which 
patients could contest decisions regarding cross-border care, perhaps such 
as requirements to designate fair appeals procedures and timetables. The 
Commission is adamant that patients must have adequate information to 
make informed choices about treatments and providers in other Member 
States. This, in order to give substance to the freedom to receive medical 
services in another Member State of the European Union.
• Question 3: Which issues (e.g. clinical oversight, financial responsi­
bility) should be the responsibility of which country?
• Specific issues here, according to the Commission, include continuity 
of care when a patient travels to another Member State to undergo 
medical treatment after which he returns to his own Member State.
• Question 4: Who should be responsible for ensuring safety in the 
case of cross-border health care? If patients suffer harm, how should 
redress for patients be ensured?
• An issue of importance highlighted by the Commission is the need to 
be clear about who is responsible for ensuring patient safety in cross­
border health care; how patients will be compensated when they su­
ffer harm; if there are errors, whose liability rules will apply and how 
those errors will be followed up so as to avoid repetition.
• Question 5: W hat action is needed to ensure that treating patients 
from other Member States is compatible with the provision of a ba­
lanced medical and hospital services accessible to all in the ‘receiving’ 
country?
The proportion of patient mobility can be higher in border regions 
or popular tourist destinations, explains the Commission. Greater cla­
rity is needed over the possibilities given to the Member State of tre­
atment i.e. the ‘receiving country’ to ensure that treatment given to 
patients from other Member States will not prevent the provision of 
a balanced health care service open to all or undermine the sustainabi­
lity of the health system of the receiving Member State.
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• Question 6: Are there further issues to be addressed in the specific 
context of health services regarding the establishment of health care 
providers not already addressed by Community legislation?
• The Commission is of the opinion that there should be clarity over 
ethical issues, and the ability of Member States to take different deci­
sions about what care they consider appropriate to provide, for exam­
ple, fertility treatment.
• Question 7: Are there other issues where legal certainty should also 
be improved? In particular, what improvements do those directly in ­
volved in receiving patients from other Member States, such as heal­
thcare providers and social security institutions, suggest in order to 
facilitate cross-border health care?
• Question 8: In what ways should European action help support the 
health systems of the Member States?
• The Commission advocates the need for a formal Community frame­
work to ensure that co-ordinated action between all Member States 
will be implemented effectively and on a sustained basis in order to 
bring added value to national health systems.
• European networks of centres of reference are suggested, as is realising 
the potential of health innovation to ensure that treatment is provided on 
the basis of the best scientific evidence. A shared evidence base would 
improve the availability and comparability of health care data.
• Question 9: What Community tools or instruments would be appro­
priate to tackle the different issues related to health services?
Legal certainty would be best ensured, emphasises the Commission, 
by a binding legal instrument in the form of a Regulation or Directive 
based on Article 95 EC, the approximation of laws for the attainment 
of the internal market legal basis.
An interpretive Communication of case law is projected as a possi­
bility. Other non-legislative options would include practical co-ope­
ration through the High level Group on health services and medical 
care,35 together with the open method of co-ordination supporting
35 Documents of the High level Group and its working groups are available on the Internet at
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Member States in the reform and development of health care.36 Al­
though valuable in taking forward practical co-operation between 
Member States, the Commission underlines the fact that they alone 
would not provide legal certainty for patients and Member States con­
cerning the freedom to receive medical services in another European 
Union Member State. There is an increasing need in the face of incre­
ased expectations, new medical technologies, dissemination through 
information technology and the enlargement of the European Union, 
concludes the Commission, to reconcile national health policies with 
the obligations of the internal market.
It is interesting to note that the Commission includes, in its Legisla­
tive and Work Programme for 2007,37 a legislative proposal for a Com­
munity Framework for safe and efficient health services with Article 
95 of the European Community Treaty as its legal basis. Its specific 
objective is stated to be to establish a Community framework for safe, 
high-quality and efficient health services in order to:
• ensure patient safety wherever health care is provided throughout 
the Community;
• address uncertainties over application of Community law to health 
services that create obstacles to cross-border healthcare;
• improve the efficiency and effectiveness of health services throughout 
the European Union.
The United Kingdom Response to the Consultation
The United Kingdom (UK) thinks that there are certain fundamental 
underlying principles that need to underpin, and be reflected in, any 
proposals in order to ensure a system of patient mobility that is mana­
http://ec.europa.eu/health/ph_overview/co_operation/mobility/high_level_documents_en.htm.
36 See further: Com (2004) 304, 20 April 2004. “Modernising social protection for the devel­
opment of high quality, accessible and sustainable health care and long-term care: support for the 
national strategies using the open method of co-ordination”.
37 COM (2006) 629, 24 October 2006.
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geable and sustainable in the long term: one that respects the rights and 
responsibilities of Member States to organise and manage their health 
care systems.38 The UK Government is adamant that the home health sy­
stem in the individual Member State needs to be able to determine what 
health care services are offered to individual patients, and to manage the 
clinical decision about whether, given the individual circumstances of 
the patient, ‘undue delay’ applies. In the UK this is done through referral 
processes as an integral part of the process of determining what health 
services will be offered to the patient. It is essential to the Government 
that such processes must be respected in any legislative proposals.
Furthermore, in the view of the UK, patient mobility must be cost- 
neutral to the home health system. According to the UK response, further 
clarification is needed of the fact that when patients request to go abroad 
in order to be treated, it is the standard of care, governance, and redress 
arrangements of the Member State of treatment that will apply. Moreo­
ver, a principle of transparency could be established making it clear what 
information should be made available to patients by providers before 
they travel abroad for treatment. The UK Government insists that there
38 UK Consultation Response to Commission Communication on Health Services, available 
on the Internet: http://ec.europa.eu/health/ph_overview/co-operation/mobility/results_open_con- 
sultation_en.htm#1. This response takes account of the views of UK stakeholders that contributed 
to a consultation in the UK, and views expressed in the UK Parliament, following appearances by 
the Right Honourable Rosie Winterton MP, the Minister of State for Health Services, before both 
a House of Commons Standing Committee, and Sub-Committee G of the House of Lords European 
Union Select Committee. Minutes of the Commons appearance are available at: http://www.publi- 
cations.parliament.uk/pa/cm200607/cmgeneral/euro/070116/70116s01.htm. Minutes of the Hou­
se of Lords appearance are published at: http://www.publications.parliament.uk/pa/ld/ldeucom. 
htm#evid, House of Lords European Union Committee 8th Report of Session 2006-07, HL Paper 
48, Cross Border Health Services in the European Union. This Report makes available the oral 
evidence provided by the Rt. Hon. Rosie Winterton MP, Minister of State for Health Services to EU 
Sub-Committee G on 25 January relating to cross border health services in the European Union. 
The meeting with the Minister helped to improve the Sub-Committee’s understanding of the signi­
ficant and sensitive issues, of both a legal and political nature, that need to be resolved in order to 
find an acceptable way forward in this case. In particular, Sub-Committee G recognised the point 
the Minister made that there was a need to get the framework for European Health Services right so 
that it can provide a fair and transparent system for people seeking health care and, at the same time, 
ensure that it does not undermine the UK health service. (Point 5 of the Report). Sub-Committee G 
will look further at these issues when the Commission publish firm proposals. (Point 6).
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must be no ‘requirement to treat’ on the part of Member States receiving 
patients travelling abroad for elective treatment. In other words, Mem­
ber States must be able to prioritise their own residents above patients 
travelling to them specifically for treatment. Further, in accordance with 
the stated position of the UK, the principles of equity and solidarity need 
to be respected with regard to patient mobility, thereby avoiding the risk 
of creating a system whereby those European Union citizens who can 
afford to pay initially for services can access health care services faster 
than those with greater needs. The UK stresses that is important that 
any proposed solution be proportionate to the demand from patients 
which may grow. Accordingly, any system that is put in place to facilitate 
patient mobility needs to be both sustainable and flexible enough to take 
account of long term developments. Finally, the government underline 
that any legislative proposal should be based on the fundamental prin­
ciples spelt out in its response and should not be overly detailed, nor 
simply transpose European Court of Justice case law into legislation.
Concluding Comments
The Commission will shortly publish a formal response on the Con­
sultation and a Community legislative proposal will follow, having as 
its legal basis the Internal Market approximation of laws Article 95 EC, 
pursuant to which the European Parliament and the Council of the Eu­
ropean Union will have each have an opportunity to debate and have 
an input under the Co-decision procedure.39
It may well transpire in the legislative proposal which will ensue, that 
the substantive decision as to what constitutes ‘undue delay’ in the referral 
system for hospital treatment will remain a decision for the Member State’s 
competent authorities.40 Nevertheless procedural requirements underpin­
39 In accordance with Article 251EC.
40 It is interesting to note that the Court of Appeal has not yet applied the preliminary ruling 
delivered by the European Court of Justice in the Watts case on 16 May 2006. It is for that refer­
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ning this decision will, inevitably, be laid down by Community law. The 
conditions on which the grant of prior authorisation must be based; the fact 
that these must be transparent, objectively justified and detailed in advan­
ce in order to circumscribe any potential for the exercise of administrative 
discretion will, it is submitted, be part and parcel of the draft Community 
legislation. Adequate judicial review mechanisms will have to comply with 
principles of European Community law. Procedural transparency and ava­
ilable information for patients to enable them to choose to receive hospital 
treatment in another European Member State in individual circumstances 
when that treatment cannot be made available to them in the time deemed 
necessary having regard to their clinical condition etc. will emanate from 
European Community law. A lack of such information would constitute 
a potential barrier to the exercise of the fundamental freedom to receive 
cross-border treatment. Important issues such as the duty of care; liability 
and compensation mechanisms; and after care service will also feature in 
a European Community legislative act. It is this author’s opinion that the 
form of European Community law will be a Framework Directive which 
will, in accordance with the principle of subsidiarity,41 leave an element 
of flexibility in transposition to take account of the diverse systems that 
exist in the Member States. The freedom to choose to receive urgent health 
care in another European Union Member State will be facilitated and also 
circumscribed within a Community framework which will provide legal 
certainty for both patients and Member States.
ring court to decide on the facts inter alia whether there was ‘undue delay’ in according hospital 
treatment to Mrs Yvonne Watts. The formal outcome of the Consultation regarding Community 
Action on Health Services is, no doubt, awaited.
41 See: Article 6 of the Protocol on the Application of the Principles of Subsidiarity and Pro­
portionality annexed to the European Community Treaty.
